A University of Oklahoma study about a "black box warning" for the asthma drug Singulair continues to influence a national conversation about the medication and its reported neuropsychiatric side effects in children and adolescents. ...
Apr 5, 2024
0
24
Scientists from the U.S. Food and Drug Administration conclude in newly released documents that marijuana has less potential for abuse than other drugs with the same restrictions and it should be reclassified as a less dangerous ...
Jan 15, 2024
0
3
Leading e-cigarette researchers are urging the U.S. Centers for Disease Control & Prevention (CDC) to correct misinformation overstating the dangers of e-cigarettes as part of its "Moving Forward" initiative.
Dec 14, 2022
0
6
A coalition of US states has urged President Donald Trump to lift a ban on fetal tissue research in a bid to help scientists developing vaccines for the new coronavirus.
Mar 26, 2020
0
1
More companies could begin making an easy-to-use version of an opioid overdose antidote under a deal announced Thursday by New York's attorney general.
Jan 2, 2020
0
4
Israeli pharmaceutical giant Teva agreed on Sunday to pay the US state of Oklahoma $85 million to settle a lawsuit accusing it of fueling the state's opioid epidemic, Oklahoma's attorney general said.
May 27, 2019
0
1
As scientists try to research the medical benefits of marijuana, a simple problem has emerged: How do you research marijuana if no one can produce it under federal law?
May 12, 2018
0
6
Dawna Hankins was scheduled to have a partial hysterectomy in 2008 when her doctor suggested implanting a vaginal mesh device at the same time to deal with minor incontinence.
May 25, 2016
0
1
Since Kentucky's landmark prescription drug abuse legislation took effect in 2012, the Commonwealth has seen a significant decline in the number of prescriptions for the most commonly abused medications, doctor shopping has ...
Jul 28, 2015
0
20
The U.S. Food and Drug Administration must hold companies to a higher standard when it comes to herbal supplements, said Edward Bednarczyk, University at Buffalo pharmacy practice chair, PharmD.
Apr 8, 2015
0
28
